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Postoperative biliary stricture is a relatively rare but 
serious complication of biliary surgery. Although Roux- 
en-Y hepaticojejunostomy or choledochojejunostomy 
are well-established and fundamental therapeutic ap-
proaches, their postoperative morbidity and mortality 
rates have been reported to be up to 33% and 13%, 
respectively. Recent studies suggest that percuta-
neous transhepatic intervention is an effective and 
less invasive therapeutic modality compared with tradi-
tional surgical treatment. Compared with fluoroscopic 
intervention, percutaneous with cholangioscopy may 
be more useful in biliary strictures, as it can provide 
visual information regarding the stricture site. We re-
cently experienced two cases complete membranous 
occlusion of the bilioenteric anastomosis and success-
fully treated both patients using percutaneous trans-
hepatic cholangioscopy. (Gut and Liver 2009;3: 
352-355)
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INTRODUCTION
  Benign postoperative biliary stricture is one of the seri-
ous complications of biliary surgery. Although the bil-
ioenteric anastomosis has become the traditional treat-
ment of choice for patients with benign biliary strictures, 
recent studies suggested that percutaneous transhepatic 
therapy would be an effective and less invasive ther-
apeutic modality.
1,2 Both fluoroscopy and cholangioscopy 
can guide the percutaneous balloon dilation with or with-
out stent insertion. Compared with fluoroscopic inter-
vention, percutaneous transhepatic cholangioscopy (PTCS) 
may be more useful in biliary strictures, as it can provide 
a direct vision on the stricture site and, if needed, biopsy 
specimens for tissue diagnosis.
3 Recently, we experienced 
two cases with complete membranous occlusion of the 
bilioenteric anastomosis and successfully treated both pa-
tients using percutaneous transhepatic cholangioscopy.
CASE REPORT
1. Case 1
    A 60-year-old male was admitted with fever and 
jaundice. He had undergone cholecystectomy 23 years pri-
or to admission and, 1 year after this procedure, he un-
derwent Roux-en-Y hepaticojejunostomy due to post-
operative biliary stricture. He had been admitted three 
times during the last 4 years because of recurrent chol-
angitis and intrahepatic duct stones. The anastomosis site 
was patent on cholangiography and PTCS at each 
a d m i s s i o n .  F i v e  m o n t h s  a f t e r  t h e  l a s t  a d m i s s i o n ,  h e  w a s  
again admitted for fever that had developed 1 day earlier. 
His body temperature was 36.9
oC, but he was grossly 
icteric. Laboratory tests revealed a white blood cell count 
of 27,400/mm
3, aspartate aminotransferase of 199 IU/L 
(reference range, ＜40 IU/L), alanine aminotransferase of 
242 IU/L (＜40 IU/L), alkaline phosphatase of 269 IU/L 
(40-120 IU/L), gamma-glutamyl transferase of 330 IU/L 
(11-63 IU/L), total bilirubin of 8.0 mg/dL (0.2-1.2 Yang DH, et al: PTCS for Complete Membranous Occlusion of Bilioenteric Anastomosis   353
Fig. 1. (A) Case 1. The arrows 
indicate the small, dark, dimpled 
spot, and the arrowheads indi-
cate scar changes. (B) Case 1. 
The dark, dimpled spot was 
tapped lightly and repetitively 
with the flexible end of the 
guide wire. (C) Case 2. The 
arrows indicate the dimpled le-
sion, which appears fibrotic. (D) 
Case 2. The lesion was tapped 
lightly and repetitively with the 
flexible end of the guide wire.
mg/dL), and direct bilirubin of 3.9 mg/dL (＜0.5 mg/dL).
  A computed tomography (CT) scan showed that both 
intrahepatic ducts were diffusely dilated. Percutaneous 
transhepatic biliary drainage catheter insertion and sub-
sequent PTCS were performed. The contrast medium did 
not pass through the anastomosis site and a dark dimpled 
spot was observed on the confluent portion of the two 
main intrahepatic bile ducts (Fig. 1A). There was no ab-
normal vessel or mucosal nodularity suggesting malig-
nancy around the lesion. The dimpled spot was repeatedly 
tapped with the flexible end of the guidewire and the 
guidewire then passed through the anastomosis (Fig. 1B). 
After balloon dilation, an 18-Fr drainage catheter was 
passed through the anastomosis (Fig. 2). Repeated PTCS 
after 2 months and 8 months revealed suboptimal patency 
of the anastomosis site. Therefore, additional dilation was 
performed. A clamped catheter was maintained in the 
anastomosis site, and follow-up PTCS was scheduled to 
assess patency.
2. Case 2
  The second case was a 26-year-old woman with post-
prandial right upper quadrant abdominal pain. She had 
undergone an operation for removal of a hepatic mass in-
cluding hepaticojejunostomy 25 years prior to admission. 
During the last 5 years, her blood chemistry tests re-
peatedly showed elevated levels of aspartate and alanine 
aminotransferase. Two years prior to admission, she had 
experienced an episode of self-limiting jaundice, and suf-
fered from postprandial abdominal pain and jaundice for 
the 3 days before admission. A complete blood count 
showed WBC at 3,300/mm
3, hemoglobin of 12.1 g/dL, 
and a platelet count of 102,000/mm
3. Blood chemistry 
tests revealed aspartate aminotransferase of 54 IU/L, ala-
nine aminotransferase of 100 IU/L, alkaline phosphatase 
of 381 IU/L, gamma-glutamyl transferase of 182 IU/L, to-
tal bilirubin of 2.2 mg/dL, and direct bilirubin of 0.8 
m g / d L .  A  C T  s c a n  s h o w e d  s p l e n o m e g a l y  a n d  c i r r h o t i c  
change in the remnant liver with multiple intrahepatic 
stones in dilated intrahepatic ducts. No contrast medium 
passed through the bilioenteric anastomosis when chol-
angiography was performed. Cholangioscopy showed a 
small dimple on the anastomosis site without any finding 
suggestive of malignancy. Repetitive tapping on this le-
sion with the flexible end of the guidewire created a pas-
sage to the jejunum, and balloon dilation was performed. 354   Gut and Liver, Vol. 3, No. 4, December 2009
Fig. 2. Serial images of guide-wire insertion and balloon dilation (A-D, case 1; E and F, case 2). Images A and E show no contrast
passage through the anastomosis sites, suggesting complete occlusion. After gentle tapping with the flexible end of the guide wire,
balloon dilation was performed in each case (B-D, case 1; F, case 2).
The dilated site was well-maintained on PTCS after 2 
months and our patient has experienced no significant 
symptoms for the last 14 months.
DISCUSSION
  Postoperative benign biliary stricture is one of the seri-
ous complications of biliary surgery, and, if left untreated, 
can lead to recurrent cholangitis, recurrent choledochol-
ithiasis, biliary cirrhosis, hepatic failure, and death.
4-7 
Roux-en-Y hepaticojejunostomy or choledochojejunostomy 
are well-established therapeutic approaches for this con-
dition. However, because of the relatively high post-
operative morbidity rate (13-33%)
8,9 and significant post-
operative mortality rate (2-13%)
2,9-11 of these techniques, 
cholangioscopic intervention has become popular as a 
therapeutic option. Reoperation for recurrent biliary stric-
ture after bilioenteric anastomosis is technically difficult, 
and surgery on patients with liver cirrhosis or portal hy-
pertension is associated with serious morbidity and high 
mortality. Thus, balloon dilation via PTCS is the preferred 
treatment option in these difficult situations. After identi-
fying the stricture by imaging, percutaneous transhepatic 
biliary drainage catheter insertion, sinus tract dilation, 
and PTCS are sequentially performed, and, if a benign 
stricture is revealed, balloon dilation can be attempted. 
Guidewire insertion through the stricture site is necessary 
for balloon dilation, but, in some situations, such in-
sertion is difficult or impossible. In our cases, the anasto-
mosis sites were completely occluded. However, metic-
ulous examination revealed the anastomosis sites to us, 
and the dimpled spots suggested the thinnest part of the 
occluded anastomosis sites. Guidewires could be advanced 
through the anastomotic lumens after gentle tapping with 
the flexible ends of the guidewires. To our knowledge, 
this is the first report on PTCS-based intervention in the 
treatment of the benign complete occlusion of bilioenteric 
anastomosis.
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